1. Region I IPP Data Presentation Advisory Board Meeting June 2008 Wells, ME

2. Overview Positivity Progress towards Regional Goals and Objectives Infrastructure Performance Measures

4. Chlamydia Positivity in Region I Family Planning Females by Year % Positive

5. Region I Chlamydia Positivity Family Planning Females by State and Year % Positive

6. Regional Goals and Objectives Objective 1.1 By 2010, increase by 10% the number of young sexually active men and women at risk for Chlamydia who are screened, using 2004 as a measure.

7. Objective 1.1 2004 data as a baseline increase from by 10% in IPP sites.

8. Objective 1.1

9. Regional Goals and Objectives Objective 2.2 By 2010, no more than 5% of the woman more than 25 years of age with no risk factors will be screened in IPP funded clinics, i.e. 95% will be screened according to regional screening criteria

10. Risk factors include the following variables: CLINICAL Factors - Muco -PID -Femaleother REASON FOR EXAM -Symptomatic for STD RISK HISTORY -Two -Newsex -Std -Condom -Consist -Partner

11. Among women who test Positive, % with Risk Factors Family Planning, Females Only, Age 25+* % With Risk Factors * For MA, for 2004 to 2006 run as 30+, and 2007 run as 26+

12. Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened) Percent

13. Connecticut, % with Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened) Percent

14. Maine, % with Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened) Percent

15. Massachusetts, % with Risk Factors Family Planning Clinics, Women, 26+ (Objective 2.2: ≥95% screened) Percent

16. New Hampshire, % with Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened) Percent

17. Rhode Island, Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened) Percent

18. Vermont, % with Risk Factors Family Planning Clinics, Women, 25+ (Objective 2.2: ≥95% screened) Percent

19. Infrastructure Performance Measures Performance Measure 1 –Screening Coverage Estimate (FPAR data) Numerator: Number of women screened in Family Planning Clinics Denominator: Number of women eligible to be screened

20. Infrastructure Performance Measures Estimated Screening Coverage by Age Category 2005-2007 Percent

21. Infrastructure Performance Measures In 2007: –Increased screening in the 15-19 and 20-24 age categories over the past 2 years 15-19 screening rose from 35.6% in 2005 to 42.5% in 2007 20-24 screening rose from 34.1% in 2005 to 40.2% in 2007 –Decreased screening in females over 24 over the past 2 years Screening >24 went from 40.5% in 2005 to 32.8% in 2007 Goal for 2008 –Increase the number of women age 24 and under by at least 3% –Decrease the number of women age 24+ by at least 3%

22. Infrastructure Performance Measures Performance Measure 2 Chlamydia Screening Test Utilization Proportion of total tests by age category (Region I IPP Data) –Numerator: Number of women tested by age category in Family Planning Clinics –Denominator: Total number of women tested

23. Infrastructure Performance Measures Proportion of Female Tests Utilized, 2005-2007

24. Infrastructure Performance Measures In 2007 –Very little change over the past 3 years for all 4 age categories Could be a result of budget cuts –Proportion of tests done on women age 29+ is high Could be because data is not broken down by those with and without risk factors, CDC recommends testing age 26+ with risk factors Goal for 2008 –Increase the proportion of tests utilized by women between the ages of 15-24 from 0.31 to 0.35 –Decrease the proportion of tests utilized by women 29+ from 0.27 to 0.2

25. Future Analyses Rescreening and re-infection rates Screening coverage Improving quality of data Cost effectiveness (age criteria, male screening, clinic types, etc)